Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream.

JAAD Case Rep

Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut; Department of Veterans Affairs, West Haven, Connecticut.

Published: March 2016

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810288	PMC
http://dx.doi.org/10.1016/j.jdcr.2016.01.004	DOI Listing

Publication Analysis

treatment melanoma

melanoma in-transit

in-transit metastases

metastases combination

combination intralesional

intralesional interleukin-2

interleukin-2 topical

topical imiquimod

imiquimod tretinoin

tretinoin 01%

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!